OnabotulinumtoxinA to Prevent Chronic Migraine with Comorbid Bruxism: Real-World Data from the GRASP Study Group
BoNTA exerts dual beneficial effects towards both the reduction of migraine frequency and the alleviation of bruxism-related pain and disability. Both of these effects seem closely interrelated in our study.
Authors
- Aikaterini Foska (ORCID: https://orcid.org/0000-0002-5164-4952)
- Maria Chondrogianni (ORCID: https://orcid.org/0000-0002-8315-5846)
- Dimitrios Rikos (ORCID: https://orcid.org/0000-0003-2346-5057)
- Georgia Xiromerisiou (ORCID: https://orcid.org/0000-0001-7162-3588)
- Panagiotis Soldatos
- Michail Vikelis (ORCID: https://orcid.org/0000-0002-2715-7898)
- Andreas A. Argyriou (ORCID: https://orcid.org/0000-0003-2131-7114)
- Pantelis Litsardopoulos
- Emmanouil V. Dermitzakis (ORCID: https://orcid.org/0000-0001-9275-0076)
Institutions
- National and Kapodistrian University of Athens (GR)
- Applied Minds (United States) (US)
- Agios Andreas Hospital (GR)
- 424 General Military Hospital (GR)
- University General Hospital Attikon (GR)
- Base Training (GR)
- 404 General Military Hospital (GR)
Publication Details
- Journal
- Toxins
- Published
- 2025-11-03
- DOI
- https://doi.org/10.3390/toxins17110547
- Citations
- 1
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47